VBI Vaccines

Closed

Activating the Power Within

Cambridge, United States · $35.7M raised

Headquarters
Cambridge
Employees
51–200
Business Model
B2B
Total Funding
$35.7M
Last Round
$35.7M Series AJan 2007
Rounds
1

About

VBI Vaccines Inc. (Nasdaq: VBIV) was a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, developing vaccine and immunotherapeutic candidates based on virus-like particle technology designed to closely mimic the natural presentation of viruses and elicit a potent immune response. Its pipeline targeted major unmet medical needs, including cytomegalovirus and other infectious diseases, as well as aggressive cancers such as glioblastoma. In 2024 the company initiated restructuring proceedings under Canada's CCAA and issued a voluntary nationwide recall of its PreHevbrio hepatitis B vaccine following the discontinuation of company operations.

Summary

VBI Vaccines is a Biotech company based in Cambridge, United States. It has raised $35.7M in total across 1 round, most recently a $35.7M Series A round in Jan 2007. Investors include Paulson & Co. and 5AM Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOJul 2014
$16.3M

Sign up to see all 2 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VBI Vaccines on Indexed.vc
<a href="https://indexed.vc/companies/vbi-vaccines"><img src="https://indexed.vc/api/badge/company/vbi-vaccines" alt="VBI Vaccines on Indexed.vc" width="260" height="76" /></a>